One of the main issues in biobanking is the establishment of standard operating procedure to control sample pre-analytical variation. Referring to RNA, the commonly used parameters are insufficient to reflect all changes occurring post-sampling. For an accurate evaluation of blood RNA quality, we report a broad panel of parameters including up and down regulated genes and markers related to RNA fragmentation and degradation.